These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 21164117)

  • 1. Citicoline in vascular cognitive impairment and vascular dementia after stroke.
    Alvarez-Sabín J; Román GC
    Stroke; 2011 Jan; 42(1 Suppl):S40-3. PubMed ID: 21164117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term treatment with citicoline may improve poststroke vascular cognitive impairment.
    Alvarez-Sabín J; Ortega G; Jacas C; Santamarina E; Maisterra O; Ribo M; Molina C; Quintana M; Román GC
    Cerebrovasc Dis; 2013; 35(2):146-54. PubMed ID: 23406981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Citicoline preclinical and clinical update 2009-2010.
    Dávalos A; Secades J
    Stroke; 2011 Jan; 42(1 Suppl):S36-9. PubMed ID: 21164116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dl-3-n-butylphthalide can improve the cognitive function of patients with acute ischemic stroke: a prospective intervention study.
    Yan H; Yan Z; Niu X; Wang J; Gui Y; Zhang P
    Neurol Res; 2017 Apr; 39(4):337-343. PubMed ID: 28145815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic applications of citicoline for stroke and cognitive dysfunction in the elderly: a review of the literature.
    Conant R; Schauss AG
    Altern Med Rev; 2004 Mar; 9(1):17-31. PubMed ID: 15005642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term citicoline (cytidine diphosphate choline) use in patients with vascular dementia: neuroimaging and neuropsychological outcomes.
    Cohen RA; Browndyke JN; Moser DJ; Paul RH; Gordon N; Sweet L
    Cerebrovasc Dis; 2003; 16(3):199-204. PubMed ID: 12865605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Citicoline: pharmacological and clinical review, 2006 update.
    Secades JJ; Lorenzo JL
    Methods Find Exp Clin Pharmacol; 2006 Sep; 28 Suppl B():1-56. PubMed ID: 17171187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of neuroprotection in complex rehabilitation of patients with ischemic stroke].
    Hubenia OV
    Lik Sprava; 2012; (7):88-92. PubMed ID: 23350122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The assessment of the efficacy of citicoline in the early and recovery stages of stroke].
    Shavlovskaya OA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(6):93-97. PubMed ID: 28635796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind placebo-controlled study with citicoline in APOE genotyped Alzheimer's disease patients. Effects on cognitive performance, brain bioelectrical activity and cerebral perfusion.
    Alvarez XA; Mouzo R; Pichel V; Pérez P; Laredo M; Fernández-Novoa L; Corzo L; Zas R; Alcaraz M; Secades JJ; Lozano R; Cacabelos R
    Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):633-44. PubMed ID: 10669911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotection and recovery: recent data at the bench on citicoline.
    Hurtado O; Lizasoain I; Moro MÁ
    Stroke; 2011 Jan; 42(1 Suppl):S33-5. PubMed ID: 21164125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Citicoline in the treatment of acute ischaemic stroke: an international, randomized, multicentre, placebo-controlled study (ICTUS trial) is the use of Citicoline is beneficial for acute ischaemic stroke?
    Nomani F; Kamal AK
    J Pak Med Assoc; 2013 Nov; 63(11):1445. PubMed ID: 24392540
    [No Abstract]   [Full Text] [Related]  

  • 13. [Neuroprotection in acute ischemic stroke. Practicability of guidelines for treatment].
    Fridman EA; Ottaviano F; Fiol M; Javelier A; Perea JE; Ameriso SF
    Rev Neurol; 2001 May 1-15; 32(9):818-21. PubMed ID: 11424030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of citicoline on acute ischemic stroke: a review.
    Overgaard K
    J Stroke Cerebrovasc Dis; 2014 Aug; 23(7):1764-9. PubMed ID: 24739589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of vascular dementia-evidence from clinical trials with cholinesterase inhibitors.
    Erkinjuntti T; Román G; Gauthier S
    Neurol Res; 2004 Jul; 26(5):603-5. PubMed ID: 15265282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Citicoline, use in cognitive decline: vascular and degenerative.
    García-Cobos R; Frank-García A; Gutiérrez-Fernández M; Díez-Tejedor E
    J Neurol Sci; 2010 Dec; 299(1-2):188-92. PubMed ID: 20875651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Citicoline. Ferrer Internacional.
    Alexandrov AV
    Curr Opin Investig Drugs; 2001 Dec; 2(12):1757-62. PubMed ID: 11892942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probably role of citicoline in stroke rehabilitation: review of the literature.
    Secades JJ
    Rev Neurol; 2012 Feb; 54(3):173-9. PubMed ID: 22278894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The efficacy of recognan in the early stage of ischemic stroke].
    Mashin VV; Belova LA; Dudikov EM; Bergelson TM; Lankov VA; Zakuraeva KA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(10):44-48. PubMed ID: 29171488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Influence of neuroprotectors with choline-positive action on the level of brain-injury markers during acute ischemic stroke].
    Vaizova OE; Zautner NA; Alifirova VM; Vengerovskiĭ AI
    Eksp Klin Farmakol; 2012; 75(3):7-9. PubMed ID: 22679745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.